Updated Date:
01 Dec 2025
Product Detail:
EDRONAX reboxetine 4mg (as mesilate) tablet blister pack
Shortage Status:
Anticipated
AUST R:
79745
Availability:
Available
Active Ingredient:
reboxetine mesilate
Reason:
Commercial Changes / Commercial viability
Dosage Form:
Tablet,uncoated
Supply Impact Dates
From 16 Mar 2026
To 25 May 2026
Management Action:
